n-(2-cyclohexyloxy-4-nitrophenyl)methanesulfonamide has been researched along with Liver Cirrhosis in 2 studies
N-(2-cyclohexyloxy-4-nitrophenyl)methanesulfonamide: structure given in first source
NS-398 : A C-nitro compound that is N-methylsulfonyl-4-nitroaniline bearing an additional cyclohexyloxy substituent at position 2.
Liver Cirrhosis: Liver disease in which the normal microcirculation, the gross vascular anatomy, and the hepatic architecture have been variably destroyed and altered with fibrous septa surrounding regenerated or regenerating parenchymal nodules.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kang, SH | 1 |
| Yim, HJ | 1 |
| Hwang, JW | 1 |
| Kim, MJ | 1 |
| Lee, YS | 1 |
| Jung, YK | 1 |
| Yim, H | 1 |
| Kim, BH | 1 |
| Park, HC | 1 |
| Seo, YS | 1 |
| Kim, JH | 1 |
| Yeon, JE | 1 |
| Um, SH | 1 |
| Byun, KS | 1 |
| HE, YJ | 1 |
| PAN, J | 1 |
| SHU, JC | 1 |
| SHEN, Y | 1 |
| LV, X | 1 |
| FANG, L | 1 |
2 other studies available for n-(2-cyclohexyloxy-4-nitrophenyl)methanesulfonamide and Liver Cirrhosis
| Article | Year |
|---|---|
Improved anti-fibrotic effects by combined treatments of simvastatin and NS-398 in experimental liver fibrosis models.
Topics: Animals; Cyclooxygenase 2 Inhibitors; Hepatic Stellate Cells; Liver; Liver Cirrhosis; Mice; Nitroben | 2022 |
[The role and mechanisms of cyclooxygenase-2 inhibitors on the proliferation of hepatic stellate cell].
Topics: Animals; Apoptosis; Cell Cycle; Cell Line; Cell Proliferation; Cyclooxygenase 2; Cyclooxygenase Inhi | 2009 |